All News

“It is important to note that the data predates the widespread use of BTK inhibitors and even cellular therapies such as CAR T-cell therapy, specifically,” Dr. Reem Karmali said in an interview. “And so, it doesn't reliably reflect the potential advancements and survival that we've been able to achieve with these novel targeted therapies.”

“As people go through the process, it’s important that you don't minimize community health workers that are not certified because at the end of the day that paper doesn't create the bond,” says Rosalia Guerrero-Luera.

Immunotherapy is a wonderful testament to the benefits that arise from our growing understanding of the incredibly intricate human immune system.

No longer were cancer fighters on another planet. We were right there with you, commiserating through the hardships and sharing the latest entertainment finds to help pass the time.

In the 2020 special issue of CURE on Immunotherapy, we take a look at how the field of immunotherapy continues to grow despite challenges from the COVID-19 pandemic.

Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.

A fellow cancer survivor mourns the passing of Kathy LaTour.

Celebrating is a vital part of survivorship and those affected by cancer should be allowed to voice their opinions openly.

From a care team giving a patient with metastatic breast cancer a taste of Paris after a planned trip had to be canceled to a local group of veterans honoring one of their own after a lung cancer diagnosis, here’s what’s making the headlines in the cancer space this week.

For survivor Michele Grimes, time at home during the pandemic fosters an opportunity for reflection and growth.

Incessant and challenging these diseases demand our equal attention in our lives.

This week’s “Cooking with CURE” recipe makes it easy to include more vegetables into your diet, with a delicious egg hash that is sure to be a hit.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for June 2020.

The Food and Drug Administration approved Bavencio as a first-line maintenance therapy for patients with locally advanced or metastatic urothelial carcinoma.

“I had the honor of spending time with Kathy at CURE's inaugural Ovarian Cancer Heroes ceremony. She was such a nice, helpful person and did so much for the cancer survivor community,” one Facebook user wrote about CURE Magazine co-founder Kathy LaTour.

A cancer journey influences how a person contemplates retirement. In my case, it inspired me to retire from teaching earlier than I had originally planned.

Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.

Keytruda bested chemotherapy, delaying disease progression or death by 40%, in a clinical trial that led to the drug’s approval for use as a single initial treatment for patients with colorectal cancer.

A PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.

The aim is to explore the magnitude of the problem and give researchers and clinicians new insights to improve the quality of life for women lung cancer survivors.

“With a new administration route, Phesgo offers an outpatient option for patients to receive (Perjeta) and (Herceptin),” Dr. Richard Pazdur said in a press release issued by the FDA.

Breast pain during the pandemic is extra worrisome, but finding an explanation for it is sometimes much simpler.

In its first virtual performance, the Visible Ink writing therapy program at Memorial Sloan Kettering Cancer Center shared works by patients and staff members that touched on the COVID-19 pandemic and were interpreted by celebrity actors, singers and dancers.

Follow up appointments can be scary and nerve-racking for patients anticipating potentially bad, or confusing, news. However, one survivor details steps to help with anxiety around oncology follow up appointments.

Takeaways from 3 months of video tele-mental-health care during cancer treatment amid the coronavirus pandemic.

In an interview with CURE®, Dr. Mazyar Shadman discussed the enormous variety of treatment preferences among patients with CLL and said that emphasis should be placed on treating each person according to their wishes.

“These things cannot just shut down completely because these diseases don't exist in isolation,” says Dr. Paul Paik.

In honor of CURE co-founder Kathy LaTour, who passed away June 19, 2020, a fellow VOICES writer shares the lessons she learned by reading Kathy’s insightful words.